Physician profile
Stephen W Jackson
NPI 1386609808
$480.21
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.55 · 2020: $33.18 · 2021: $14.28 · 2022: $12.59 · 2023: $134 · 2024: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $333.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $121.04 | 2019-2024 | Xtandi |
| Boston Scientific Corporation | $113.31 | 2024 | Rezum Generator, Ams 700 |
| Astrazeneca Pharmaceuticals LP | $55.68 | 2023 | Lynparza |
| Teleflex LLC | $39.02 | 2023 | Urolift |
| Abbvie INC. | $29.50 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $24.34 | 2023 | Keytruda, Lynparza |
| Blue Earth Diagnostics | $18.65 | 2019 | |
| 180 Medical, INC. | $14.68 | 2023 | |
| Coloplast Corp | $14.28 | 2021 | |
| Ferring Pharmaceuticals INC. | $12.98 | 2019 | |
| Hollister Incorporated | $12.59 | 2022 | |
| Allergan, INC. | $12.15 | 2019 | |
| Medtronic USA, INC. | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.